Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States.

Cecilia Monge BonillaJ Alberto MaldonadoKatherine A McGlynnTim F Greten

Published in: Journal of hepatocellular carcinoma (2023)

Hispanic individuals are disproportionately underrepresented in multinational phase III clinical trials for liver cancer despite having the highest relative incidence rates among the four major racial or ethnic groups in the US.

Keyphrases

phase iii
clinical trial
african american
open label
phase ii
double blind
risk factors
placebo controlled
study protocol